Our division supports research programs that foster emerging areas in basic #CancerResearch and the development of new experimental models. https://lnkd.in/e_BryHC9
NCI Division of Cancer Biology
Government Administration
Rockville, Maryland 6,136 followers
Supporting fundamental cancer research that lays the foundation for advances in cancer prevention, diagnosis & treatment
About us
The Division of Cancer Biology (DCB) of the National Cancer Institute (NCI) supports basic research in all areas of cancer biology, from structural insights to mechanisms of metastasis. These fundamental studies provide the building blocks to new cancer prevention and diagnostic strategies, clinical trials, and anti-cancer treatments. NCI Privacy Policy: https://www.cancer.gov/policies/privacy-security
- Website
-
https://www.cancer.gov/about-nci/organization/dcb
External link for NCI Division of Cancer Biology
- Industry
- Government Administration
- Company size
- 501-1,000 employees
- Headquarters
- Rockville, Maryland
Updates
-
Interested in applying for a research grant in fundamental #CancerResearch? Check out NCI Division of Cancer Biology supported #FundingOpportunities: https://lnkd.in/exzjG3nm
DCB Funding Opportunities
cancer.gov
-
NCI Division of Cancer Biology reposted this
Happening this week! ⏰ Join NIH policy experts on Thursday, October 17 as they share essential updates and address how these changes might impact your institution’s compliance process, policies, and procedures. Register: https://go.nih.gov/b6zfhK3 #NIHgrantsevents #NIHgrants
-
In a National Cancer Institute (NCI) funded study, Lawrence Andrews, Dario Vignali, et al. found that LAG-3 and PD-1 (immune checkpoints) synergize to drive T cell exhaustion and suppress anti-tumor immunity. https://lnkd.in/g-aCSsc5
LAG-3 and PD-1 synergize on CD8 T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
cell.com
-
Join National Cancer Institute (NCI) Institute for the 19th International Conference on Malignancies in HIV/AIDS. Recent advances in areas such as viral oncology, immunology, genetics, epidemiology, pathogenesis, early diagnosis, and clinical research will be presented.
This content isn’t available here
Access this content and more in the LinkedIn app
-
NCI Division of Cancer Biology reposted this
Today’s research is tomorrow’s cure. Hear from several young cancer researchers who attended our Annual Junior Investigator Meeting who believe we can end cancer as we know it. #NationalCancerPlan Special thanks to our interviewees: Katie Houlahan of McMaster University, Kolade Adebowale of Harvard University, Maria Ulloa-Navas of Mayo Clinic, Billy Hill of Radboudumc, Rohan Panaparambil of The Johns Hopkins University School of Medicine, Rosela Golloshi of The Johns Hopkins University, Kacey Ronaldson of Columbia University, and Md Torikul Islam of The University of Texas Southwestern Medical School.
-
In a study funded by our division, Wolf et al. showed that CD4 T cells engineered with specific T cell receptor (TCRs) reprogram the tumor microenvironment and block cancer progression as an #immunotherapy in preclinical models. https://lnkd.in/e59mJV99
CD4 T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy
science.org
-
Our division is helping to Optimize the Workforce by supporting activities that help junior investigators (including graduate students, post-doctoral fellows, and early faculty) develop career skills and network with other scientists that contribute to their scientific career advancement. https://lnkd.in/dNr3Fqcw #NationalCancerPlan #Every1HasARole
DCB is Helping to Optimize the Workforce
cancer.gov
-
Using preclinical models in a study funded by a @NationalCancerInstitute MERIT Award, Duncan Morgan Stefani Spranger et al. revealed that the spleen is an important site for the response to immune checkpoint blockade. https://lnkd.in/ez-agPGq
Expansion of tumor-reactive CD8 T cell clonotypes occurs in the spleen in response to immune checkpoint blockade
science.org
-
Meet a National Cancer Institute (NCI) Division of Cancer Biology Investigator! Congzhou Wang engineers new materials for cancer therapies and encourages undergraduate students to explore fundamental #CancerResearch. https://lnkd.in/ecG76dxK #NCICancerBioProgress
Dr. Congzhou Wang Engineers New Materials to Target Cancer Cells
cancer.gov